The marine environment is an exceptional reservoir of bioactive natural products having potential biomedical applications, many of which differ from those of terrestrial organisms in both chemical structures and peculiarities of biological actions.
The marine environment is an exceptional reservoir of bioactive natural products having potential biomedical applications, many of which differ from those of terrestrial organisms in both chemical structures and peculiarities of biological actions. 1) Several marine natural products have become the source of potentially novel chemical leads for the ongoing global search of therapeutic agents for the treatment of multiple disease categories. Majority of marine natural products and their derivatives are produced by invertebrates such as sponges, soft corals, tunicates, mollusks or bryozoans and currently in advanced preclinical evaluation.
Many compounds were reported from marine sources, having anti-inflammatory activity. Amomg them manoalide, a sesterterpene isolated from the sponge Luffariella variabilis 2) found to have a selective anti-inflammatory profile.
3)
The pseudopterosins 4, 5) are a family of natural products produced by sea whips in Florida and the Bahamas, also show anti-inflammatory activity. These compounds are extremely potent chemicals in reducing swellings and skin irritations and accelerating wound healing.
3) A sesterterpene, palaulol, from the sponge Fascaplysinopsis sp., 6) a sesquiterpene furan from the coelenterate, Sinularia sp. 7) and the ceramide isolated from the tunicate Cystodytes cf. dellechiajei 8) are some other anti-inflammatory agents.
Since non-steroidal compounds and sphingosine 8) derivatives were reported to have significant anti-inflammatory activity, and some of them have even entered into the clinical trial, the new sphingosine derivative (1) and the cembrenoid diterpene (2) obtained from soft corals of Sinularia crassa TIXIER-DURIVAULT and Lobophytum species respectively were evaluated for their anti-inflammatory activity. It was already reported that this diterpene has cytotoxic 9) and anti-HIV 10) activities. But so far no anti-inflammatory activity was reported. This is the first report of sphingosine derivative having anti-inflammatory activity from soft corals.
MATERIALS AND METHODS

Collection of Soft Corals
The soft corals Sinularia crassa TIXIER-DURIVAULT and Lobophytum sp., were collected in March 1993, on the coasts of the Andaman and Nicobar Islands [Kalipur (Diglipur) and Natkal Islands 93°02ЈE, 13°20ЈN] by hand picking at 1 m depth in the inter-tidal rocky region. The animals were collected in plastic net bags and brought to the shore, washed with fresh water, cut into thin slices and preserved in ethanol in plastic carboy. The large specimens with clear morphological features were separately preserved in ethanol in small plastic container for identification purpose. The organisms were brought to the laboratory for processing.
Identification The soft corals were identified as Sinularia crassa TIXIER-DURIVAULT and Lobophytum sp., through the courtesy of Dr. V. Jayasree, National Institute of Oceanography, Goa, India. The specimens of both the soft corals were deposited in National Institute of Oceanography Museum, Goa and the voucher specimens of these soft corals were also preserved in the Department of Organic Chemistry, Andhra University, Visakhapatnam, Andhra Pradesh, India with code numbers MF-VA/45, MF-VA/41 respectively.
Extraction, Isolation and Purification The extraction of the fragmented organisms Sinularia crassa (900 g) and Lobophytum sp. (2000 g) was carried out at room temperature using ethanol by percolation every four days. The process was repeated until no substantial amount was extracted. The solvent was stripped off by distillation under reduced pressure and the dark colored residue was extracted with ethyl acetate several times. The ethyl acetate soluble portion was passed over anhydrous MgSO 4 and concentrated in vacuo.
The crude extracts of Sinularia crassa (50 g) and Lobophytum sp. (30 g) were separately subjected to column chromatography (silica gel, Acme, 100-200 mesh, 500 g) using eluants of increasing solvent polarities of hexane (bp 35-80°C), hexane-ethyl acetate (0-100%) and ethyl acetatemethanol (0-100%) to get several fractions. Fractions (800 ml) were collected and monitored with silica gel G (mesh size 200, Acme) TLC. The visualization of the spots was carried out by spraying with 10% methanol-sulphuric acid reagent and heating at 105-110°C. Similar fractions were combined by observing homogeneity over silica gel G TLC. Further purification of these fractions were carried out by rechromatography onto small silica gel columns (finer than 200, Acme), eluted with solvent polarities of hexane, hexane-ethyl acetate (0-100%) and then ethyl acetatemethanol (0-100%) to yield several fractions. The fractions obtained upon elution with hexane-ethyl acetate 4 : 1 were separately subjected to reversed-phase HPLC, using a gradient of acetonitrile-water (0-100%) and methanol-water (0-100%). The eluates when crystallized from 10% methanol in chloroform afforded sphingosine derivative (1) (40 mg) 11) as colourless buttons and cembrenoid diterpene (2) (200 mg) 12) as colourless prisms. These two compounds, sphingosine derivative (1) and cembrenoid diterpene (2) were homogeneous and found to be pure when examined on silica gel G TLC plates as well as silver nitrate impregnated silica gel plates. They were characterized by mp, [a] D , UV, IR, 1 H-, 13 C-NMR and Mass spectral data. 11, 12) Anti-inflammatory Effect Animals Sprague-Dawley rats of either sex (180-200 g) procured from National Institute of Nutrition, Hyderabad, India were used in the study. The animals were housed under standard environmental conditions (temperature of 22Ϯ1°C with an alternating 12-h light-dark cycle and relative humidity of 60Ϯ5%), fed with standard diet and water ad libitum.
Carrageenin-Induced Rat Paw Edema Rats were divided into 7 groups of 6 animals each. The control group I was injected saline (1 ml/kg) into the sub-plantar region of the right hind paw. Anti-inflammatory activity was evaluated by injecting carrageenin (Sigma, 100 mg/rat) subcutaneously into the sub-plantar region of the right hind paw and measuring the induced paw edema according to the method of Winter et al. 13) One hour prior to carrageenin injection, groups III and IV were treated with sphingosine derivative (1) at the dose level of 5 mg/kg and 10 mg/kg respectively. In a similar way groups V and VI treated with cembrenoid diterpene (2) at the dose level of 5 mg/kg and 10 mg/kg respectively. Saline (1 ml/kg) given to group II was used as carrageenin treated control and the standard drug indomethacin (2 mg/kg) administered to group VII rats. All the doses were administered orally. The thickness of right paw was measured before carrageenin injection and after carrageenin injection at time intervals 1, 3, 5 and 7 h using the Zeitlin's constant loaded lever method.
14) The percentage increase of paw edema thickness is calculated using the method of Duwiejua et al.
15)
Cotton Pellet Implantation Rats were divided into four groups of six animals each. Group I used as control received 0.5 ml of 1% sodium carboxy methyl cellulose suspension orally. Group II, III and IV received sphingosine derivative (10 mg/kg), cembrenoid diterpene (10 mg/kg) and Indomethacin (4 mg/kg) in 1% sodium carboxy methyl cellulose respectively. After 1 h rats were anaesthetised with anaesthetic ether, laid on a dissection board on its back and forelegs stretched with threads. A small incision was made at groin region 16) on either side and sterilized pellets of surgical cotton weighing 9.0Ϯ1.0 mg were implanted and incision was closed, according to the method of Winter and Portar. 17) The drug treatment was continued for a period of 6 d and on the seventh day pellets were dissected out under light ether anaesthesia. They were kept separately in small glass vials, dried for 2 h at a temperature of 150°C or more till it gave a constant weight and weighed after cooling. The inhibition in granulation tissue formation was calculated by comparing with vehicle treated group.
Statistical Analysis The results are expressed as meanϮ S.E.M. Dunnet's t-test was used to verify the statistical significance at pϽ0.05 between the treated and control groups.
RESULTS
Significant percent increase in paw edema (pϽ0.001) is observed in carrageenin treated control group when compared with saline treated control group rats. When compared to carrageenin treated control group there is significant decrease ( pϽ0.001) in paw edema of sphingosine derivative (1), cembrenoid diterpene (2) and indomethacin treated groups of rats from third hour onwards (Fig. 1) . Both sphingosine derivative (1) and cembrenoid diterpene (2) at the dose levels tested (5 mg and 10 mg/kg) possessed significant anti-inflammatory activity and is very much comparable to that of standard drug indomethacin (2 mg/kg).
The anti-inflammatory activity of these compounds was also tested using cotton pellet induced granuloma model. Similar results were observed for compounds (1) and (2) at the same dose level (10 mg/kg) in this study also (Table 1) .
DISCUSSION
The methods employed to screen these compounds for anti-inflammatory activity may involve transudative, exudative or proliferative phases of the inflammatory reactions. 18) Subcutaneous injection of carrageenin into the rat paw produces plasma extravasation 19) and the inflammation produced is characterized by increased tissue water and plasma protein exudation with neutrophil extravasation and metabolism of arachidonic acid by both cyclooxygenase and lipoxygenase enzyme pathways. 20) There are biphasic effects in carrageenininduced edema. The first phase begins immediately after injection and diminishes in 1 h and the second phase begins after 1 h. 21, 22) It is suggested that the early hyperemia of carrageenin-induced edema results from the release of histamine and serotonin. 23) On the other hand, the delayed phase of carrageenin-induced edema results mainly from the potentiating effect of prostaglandins on mediator release, especially of bradykinin. 24) Cotton pellet implantation is the most suitable method for studying the efficacy of drugs against proliferative phase of inflammation.
The present study revealed that the compounds sphingosine derivative (1) and cembrenoid diterpene (2) are effective against both carrageenin induced edema and cotton pellet implantation models. This revealed that these two compounds are potent inhibitors of exudative and proliferative phases of inflammation. However the ulcerogenic activity of these compounds was not studied due to paucity of the compound, which otherwise might have provided valuable information with respect to the efficacy and safety of these compounds, when compared to indomethacin. Further studies are also required to clearly establish the mechanism of the antiinflammatory activity of these compounds. This is the first report of anti-inflammatory activity for a sphingosine derivative obtained from soft corals. 
